BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7111308)

  • 1. Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems.
    Gasic GJ; Gasic TB
    Prog Clin Biol Res; 1982; 89():429-44. PubMed ID: 7111308
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of platelets and tumor cells.
    Steiner M
    Prog Clin Biol Res; 1982; 89():383-403. PubMed ID: 7111305
    [No Abstract]   [Full Text] [Related]  

  • 3. Animal models for the study of platelet-tumor cell interactions.
    Donati MB; Rotillio D; Delaini F; Giavazzi R; Mantovani A; Poggi A
    Prog Clin Biol Res; 1982; 89():159-76. PubMed ID: 7202205
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Ambrus JL; Ambrus CM; Gastpar H
    Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of plasma, platelets, and endothelial cells in tumor metastasis.
    Gasic GJ
    Cancer Metastasis Rev; 1984; 3(2):99-114. PubMed ID: 6386144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer.
    Bhatti RA; Gadarowski J; Ray P
    Invasion Metastasis; 1996; 16(2):49-55. PubMed ID: 9030239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
    Karpatkin S; Pearlstein E; Salk PL; Yogeeswaran G
    Prog Clin Biol Res; 1982; 89():445-77. PubMed ID: 7111309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the complement system in hemostasis.
    Blajchman MA; Ozge-Anwar AH
    Prog Hematol; 1986; 14():149-82. PubMed ID: 3511516
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex hormones, complement-mediated platelet damage, and hemostasis.
    Cines D; Shattil S
    J Lab Clin Med; 1994 Apr; 123(4):464-6. PubMed ID: 8144994
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
    Gastpar H; Ambrus JL; Ambrus CM
    Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disordered function of the vascular-thrombocyte link in the hemostatic system during tumor growth].
    Liubina LV; Tlepshukov IK
    Biull Eksp Biol Med; 1989 Dec; 108(12):716-8. PubMed ID: 2634448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation inhibitors and cancer metastasis.
    Gastpar H
    Ann Chir Gynaecol; 1982; 71(3):142-50. PubMed ID: 6287902
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-tumor cell interaction.
    Seyfert UT; Hauck W; Berger H; Böhm D; Zankl H; Albert FW
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):685-97. PubMed ID: 1709902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and dissemination of malignant tumors and hemostasis].
    Kher A; Hilgard P
    Pathol Biol (Paris); 1982 Dec; 30(10):861-7. PubMed ID: 6760066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
    Honn KV; Menter DG; Onoda JM; Taylor JD; Sloane BF
    Symp Fundam Cancer Res; 1983; 36():361-88. PubMed ID: 6382514
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of platelet activation in tumor metastasis.
    Borsig L
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1247-55. PubMed ID: 18699763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development and dissemination of malignant tumors, and hemostasis].
    Kher A; Hilgard P
    Sem Hop; 1983 Apr; 59(17):1348-54. PubMed ID: 6306819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet as an inflammatory cell.
    Nachman RL; Polley M
    Trans Am Clin Climatol Assoc; 1979; 90():38-43. PubMed ID: 516229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.